View in EDS

Nonclinical Characterization of ACP-204, a Novel Selective 5-HT2A Receptor Inverse Agonist.

Saved in:
Bibliographic Details
Title: Nonclinical Characterization of ACP-204, a Novel Selective 5-HT2A Receptor Inverse Agonist.
Authors: Burstein ES; Acadia Pharmaceuticals Inc, San Diego, California. Electronic address: eburstein@acadia-pharm.com., Olsson R; Chemical Biology and Therapeutics, Department of Experimental Medical Science, Lund University, Lund, Sweden., Skold N; RG Discovery, Lund, Sweden., Jansen KE; RG Discovery, Lund, Sweden., Azar M; Behavioral Pharma, La Jolla, California., Sandiego C; Perceptive Discovery, New Haven, Connecticut., Ridler K; Perceptive Discovery, London, United Kingdom., Rabiner EA; Perceptive Discovery, London, United Kingdom., Rhodes G; GRhodes Pharma Consulting, Los Altos, California., Dey PM; Acadia Pharmaceuticals Inc, Princeton, New Jersey., Pathak S; Acadia Pharmaceuticals Inc, Princeton, New Jersey.
Source: The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2026 Jun; Vol. 393 (6), pp. 104932. Date of Electronic Publication: 2026 May 05.
Publication Type: Journal Article
Journal Info: Publisher: American Society for Pharmacology and Experimental Therapeutics Country of Publication: Netherlands NLM ID: 0376362 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-0103 (Electronic) Linking ISSN: 00223565 NLM ISO Abbreviation: J Pharmacol Exp Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42208178
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Nonclinical Characterization of ACP-204, a Novel Selective 5-HT2A Receptor Inverse Agonist.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Burstein+ES%22">Burstein ES</searchLink>; Acadia Pharmaceuticals Inc, San Diego, California. Electronic address: eburstein@acadia-pharm.com.<br /><searchLink fieldCode="AU" term="%22Olsson+R%22">Olsson R</searchLink>; Chemical Biology and Therapeutics, Department of Experimental Medical Science, Lund University, Lund, Sweden.<br /><searchLink fieldCode="AU" term="%22Skold+N%22">Skold N</searchLink>; RG Discovery, Lund, Sweden.<br /><searchLink fieldCode="AU" term="%22Jansen+KE%22">Jansen KE</searchLink>; RG Discovery, Lund, Sweden.<br /><searchLink fieldCode="AU" term="%22Azar+M%22">Azar M</searchLink>; Behavioral Pharma, La Jolla, California.<br /><searchLink fieldCode="AU" term="%22Sandiego+C%22">Sandiego C</searchLink>; Perceptive Discovery, New Haven, Connecticut.<br /><searchLink fieldCode="AU" term="%22Ridler+K%22">Ridler K</searchLink>; Perceptive Discovery, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Rabiner+EA%22">Rabiner EA</searchLink>; Perceptive Discovery, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Rhodes+G%22">Rhodes G</searchLink>; GRhodes Pharma Consulting, Los Altos, California.<br /><searchLink fieldCode="AU" term="%22Dey+PM%22">Dey PM</searchLink>; Acadia Pharmaceuticals Inc, Princeton, New Jersey.<br /><searchLink fieldCode="AU" term="%22Pathak+S%22">Pathak S</searchLink>; Acadia Pharmaceuticals Inc, Princeton, New Jersey.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220376362%22">The Journal of pharmacology and experimental therapeutics</searchLink> [J Pharmacol Exp Ther] 2026 Jun; Vol. 393 (6), pp. 104932. <i>Date of Electronic Publication: </i>2026 May 05.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+for+Pharmacology+and+Experimental+Therapeutics%22">American Society for Pharmacology and Experimental Therapeutics </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>0376362 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1521-0103 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200223565%22">00223565 </searchLink><i>NLM ISO Abbreviation: </i>J Pharmacol Exp Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42208178
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jpet.2026.104932
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 104932
    Titles:
      – TitleFull: Nonclinical Characterization of ACP-204, a Novel Selective 5-HT2A Receptor Inverse Agonist.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Burstein ES
      – PersonEntity:
          Name:
            NameFull: Olsson R
      – PersonEntity:
          Name:
            NameFull: Skold N
      – PersonEntity:
          Name:
            NameFull: Jansen KE
      – PersonEntity:
          Name:
            NameFull: Azar M
      – PersonEntity:
          Name:
            NameFull: Sandiego C
      – PersonEntity:
          Name:
            NameFull: Ridler K
      – PersonEntity:
          Name:
            NameFull: Rabiner EA
      – PersonEntity:
          Name:
            NameFull: Rhodes G
      – PersonEntity:
          Name:
            NameFull: Dey PM
      – PersonEntity:
          Name:
            NameFull: Pathak S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2026 Jun
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1521-0103
          Numbering:
            – Type: volume
              Value: 393
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: The Journal of pharmacology and experimental therapeutics
              Type: main
ResultId 1